Semi-Annual Consolidated Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7600343

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
JPY
2,410,000,000 JPY
75,946,000,000 JPY
73,623,000,000 JPY
76,034,000,000 JPY
76,034,000,000 JPY
73,929,000,000 JPY
74,979,000,000 JPY
JPY
74,979,000,000 JPY
2,365,000,000 JPY
72,614,000,000 JPY
Cost of sales
34,563,000,000 JPY
34,458,000,000 JPY
33,190,000,000 JPY
34,073,000,000 JPY
Ordinary profit (loss)
17,866,000,000 JPY
17,542,000,000 JPY
18,178,000,000 JPY
18,222,000,000 JPY
Gross profit (loss)
41,383,000,000 JPY
41,575,000,000 JPY
40,739,000,000 JPY
40,906,000,000 JPY
Selling, general and administrative expenses
Salaries
5,616,000,000 JPY
5,662,000,000 JPY
5,838,000,000 JPY
5,884,000,000 JPY
Depreciation
257,000,000 JPY
258,000,000 JPY
227,000,000 JPY
227,000,000 JPY
Amortization of goodwill
JPY
JPY
JPY
5,000,000 JPY
5,000,000 JPY
5,000,000 JPY
JPY
Selling, general and administrative expenses
23,953,000,000 JPY
24,511,000,000 JPY
22,995,000,000 JPY
23,118,000,000 JPY
Extraordinary income
197,000,000 JPY
197,000,000 JPY
495,000,000 JPY
495,000,000 JPY
Extraordinary losses
3,854,000,000 JPY
3,854,000,000 JPY
59,000,000 JPY
59,000,000 JPY
Profit (loss) before income taxes
14,209,000,000 JPY
13,885,000,000 JPY
18,613,000,000 JPY
18,657,000,000 JPY
Operating profit (loss)
JPY
1,353,000,000 JPY
17,429,000,000 JPY
15,710,000,000 JPY
17,064,000,000 JPY
17,064,000,000 JPY
17,744,000,000 JPY
17,788,000,000 JPY
JPY
17,788,000,000 JPY
1,418,000,000 JPY
16,370,000,000 JPY
Income taxes - current
4,487,000,000 JPY
4,513,000,000 JPY
4,967,000,000 JPY
4,979,000,000 JPY
Non-operating income
Interest income
6,000,000 JPY
8,000,000 JPY
Dividend income
390,000,000 JPY
385,000,000 JPY
Non-operating income
502,000,000 JPY
543,000,000 JPY
484,000,000 JPY
484,000,000 JPY
Income taxes - deferred
-175,000,000 JPY
-177,000,000 JPY
269,000,000 JPY
272,000,000 JPY
Non-operating expenses
Interest expenses
17,000,000 JPY
17,000,000 JPY
17,000,000 JPY
17,000,000 JPY
Non-operating expenses
66,000,000 JPY
66,000,000 JPY
50,000,000 JPY
50,000,000 JPY
Income taxes
4,312,000,000 JPY
4,336,000,000 JPY
5,237,000,000 JPY
5,252,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
195,000,000 JPY
195,000,000 JPY
379,000,000 JPY
379,000,000 JPY
Profit (loss)
9,897,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,549,000,000 JPY
9,897,000,000 JPY
13,376,000,000 JPY
13,376,000,000 JPY
13,376,000,000 JPY
13,376,000,000 JPY
13,405,000,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
JPY
Extraordinary losses
Impairment losses
JPY
JPY
2,994,000,000 JPY
2,994,000,000 JPY
2,994,000,000 JPY
JPY
JPY
JPY
Profit (loss) attributable to owners of parent
9,549,000,000 JPY
9,549,000,000 JPY
9,549,000,000 JPY
13,405,000,000 JPY
13,405,000,000 JPY
13,405,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-187,000,000 JPY
1,623,000,000 JPY
Remeasurements of defined benefit plans, net of tax
202,000,000 JPY
1,503,000,000 JPY
Other comprehensive income
14,000,000 JPY
3,126,000,000 JPY
Comprehensive income
9,563,000,000 JPY
16,532,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,563,000,000 JPY
16,532,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.